Medical Device Fraud Message Board


Manhattan U.S. Attorney Settles Civil Fraud Claims Against Medical Device Distributor For Selling Products Not Approved By The FDA

6 months ago in Medical Device Fraud

Distributor CareFusion Admits to Buying and Selling Unapproved Devices, Agrees to Pay $3.3 Million

Monday, May 13, 2019

Geoffrey S. Berman, the United States Attorney for the Southern District of New York, and Jeffrey E. Shuren, M.D., director of the Center for Devices and Radiological Health at the U.S. Food and Drug Administration (“FDA”), announced today that the U.S. has settled civil fraud claims under the False Claims Act against CAREFUSION CORPORATION (“CAREFUSION”), a m…

Sage Therapeutics Reports Topline Results from Pivotal Phase 3 MOUNTAIN Study of SAGE-217 in Major Depressive Disorder

21 hours ago

Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company developing novel therapies for people with debilitating brain disorders, today reported topline results from the pivotal Phase 3 MOUNTAIN Study evaluating the effect of SAGE-217 on depressive symptoms in adults with major depressive disorder (MDD). The MOUNTAIN Study did not meet its primary endpoint of a statistically significant reduction from baseline compared to placebo

Traxx Medical Holdings LLC Bills Patient 94K for Monitoring Services

6 months ago in Medical Device Fraud

I have no idea if this is actually fraud in the legal sense but it is sad and an indictment on our healthcare system to bill a patient this much a year after surgery.

Service provider:Traxx Medical Holdings LLC, an Austin company that provides neuromonitoring during spinal surgery. Neuromonitoring uses electrical signals to detect when a surgeon is causing damage to nerves.

Total bill:$94,031 for neuromonitoring services. The bill was submitted to Blue Cross and Blue Shield of Texas, which covered…

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting

22 hours ago

​GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S. subsidiary Greenwich Biosciences announced today that a variety of data, including results from completed Phase 3 trials of EPIDIOLEX (cannabidiol) oral solution CV, will be presented at the American Epilepsy Society (AES) Annual Meeting, December 6-10, in Baltimore

Telemedicine Fraud

11 months ago in Medical Device Fraud

Here's an example of what these frauds do -

I have received dozens of calls concerning braces for pain in my back, shoulders, etc., none of which is true! On those calls where I actually talked to the callers, I told them exactly that and apparently I was ignored. They told me it will cost me absolutely nothing and Medicare will pay for everything. I again told them no, I don’t need them, nor do I want them. They told me they would send them anyway and they would be absolutely free and Medicare…

Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND

23 hours ago

​Cytokinetics (Nasdaq: CYTK) today announced that new results were presented at the 30th International Symposium on ALS/MND in Perth, Australia, including additional analyses from FORTITUDE-ALS (Functional Outcomes in a Randomized Trial of Investigational Treatment with CK-2127107 to Understand Decline in Endpoints – in ALS), the Phase 2 clinical trial of reldesemtiv in patients with amyotrophic lateral sclerosis (ALS)

Medical Device Fraud News

1 year ago in Medical Device Fraud

Loading...